Table I.

Clinicopathological characteristics of study cases.

No.	Age (years)	Gender	Sizea (cm)	Margin status	Local recurrence (m)	Metastasis (location/m)	Outcome	Follow-up (m)
1	37	Female	10	NE	8	Lung/49	AWD	49
2	50	Male	5	−	No	No	NED	21
3	60	Male	5	NE	12	Lung/81	DD	86
4	56	Male	5	+	No	No	NED	18
5	53	Male	9	NE	No	No	NED	97
6	55	Male	8	NE	9	L3, abdomen/45	DD	51
7	47	Male	11	NE	34	No	NED	89
8	56	Male	8	+	No	No	NED	13
9	44	Female	6	−	25	No	NED	37
10	54	Male	5	NE	111	GM/111	DD	146
11	17	Male	9	+	20	T11-12/20	AWD	20
12	58	Male	4	NE	24	No	NED	29
13	77	Male	5	−	38	No	AWD	66
14	67	Male	7	NE	17	No	NED	30
15	49	Male	8	+	75	No	AWD	75
16	55	Male	7	−	5	No	NED	12
17	51	Female	6	+	61	No	DD	69
18	60	Female	5	NE	34	Abdomen/34	DD	81
19	51	Female	14	NE	41	No	DD	92
20	67	Male	8	+	7	No	AWD	38
21	47	Male	5	−	No	No	NED	43
22	52	Female	9	NE	23	No	AWD	23
23	27	Male	12	NE	25	No	AWD	25
24	74	Male	10	−	10	No	DD	43
25	78	Male	7	NE	6	No	DD	23
26	47	Male	4	−	No	No	NED	13
27	51	Male	8	NE	32	No	AWD	120
28	50	Male	9	−	No	No	NED	46
29	58	Female	8	NE	37	No	NED	65
30	59	Male	16	+	58	No	NED	63
31	62	Male	30	−	9	No	DD	112
32	56	Male	4	−	10	No	DD	39
33	50	Male	5	−	No	No	NED	73
34	53	Male	8	NE	No	No	NED	61
35	49	Male	6	NE	No	No	NED	45

AWD, alive with disease; DD, died of disease; NED, no evidence of disease; +, postive; −, negative; NE, not evaluable; GM, Gluteus maximus; m, months.

^aLargest diameter of tumor.